Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations

PURPOSE: BRAF mutations occur in non–small-cell lung cancer. Therapies targeting BRAF mutant tumors have recently been identified. We undertook this study to determine the clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. PATIENTS AND METHODS: We reviewed data...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Paik, Paul K., Arcila, Maria E., Fara, Michael, Sima, Camelia S., Miller, Vincent A., Kris, Mark G., Ladanyi, Marc, Riely, Gregory J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2011
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3107760/
https://ncbi.nlm.nih.gov/pubmed/21483012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.33.1280
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak